Dubai, UAE, May 24, 2023 (GLOBE NEWSWIRE) -- The global In Vitro Fertilization Market was valued at approximately USD 19.62 billion in 2022 and is expected to grow to approximately USD 33.93 billion by 2032. The market anticipates a compound annual growth rate (CAGR)of 6.2% between 2023 and 2032. The main driving factors for this market are the increasing success rate of IVF technology, increased awareness about IVF procedures, and delayed onset of pregnancy.
Since the first IVF 40 years ago, it is estimated that more than 8 million children have been born worldwide as a result of infertility in vitro fertilization (IVF). According to recent estimates, IVF and other fertility treatments could enable 400 million people, or 3% of the world's population, to live until 2100.
Get a Sample Copy of the Report: https://www.extrapolate.com/sample/healthcare-medical-devices-biotechnology/in-vitro-fertilization-market/87497
Competitive Landscape
As a result of numerous regional and domestic players, the global in vitro fertilization (IVF) industry is extremely competitive. Leading in vitro fertilization (IVF) companies are constantly focusing on expanding their product offerings and services to make a profit.
Prominent market players include:
- Cook Group Incorporated
- CooperSurgical, Inc.
- Corning Incorporated
- Ferring B.V.
- FUJIFILM Corporation
- Koninklijke Philips N.V.
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Vitrolife AB
- ZEISS Group
GLobal In Vitro Fertilization Market Segmentation:
Segmentation by Cycle
- Frozen Non-donor IVF Cycles
- Frozen Donor IVF Cycles
- Fresh Donor IVF Cycles
- Fresh Non-donor IVF Cycles
Fresh Non-donor IVF Cycles to Gain Traction Owing to High Success Rates
In 2022, the fresh non-donor IVF cycles segment dominated the market. This is because fresh non-donor IVF cycles have a high success rate. Due to this high success rate and ease of implantation, most fertility treatment clinics prefer a new non-donor IVF cycle.
Inquire Before Buying This Report: https://www.extrapolate.com/enquire/healthcare-medical-devices-biotechnology/in-vitro-fertilization-market/87497
Market Segmentation by End User
- Fertility Clinics
- Hospitals
- Clinical Research Institutes
Rapid Expansion of Fertility Clinics Globally to Promote Growth
In 2022, the fertility clinics segment held the largest market share. This is due to the rapid expansion of fertility clinics worldwide. Furthermore, the availability of advanced assisted reproductive technologies has encouraged consumers to seek IVF treatment at fertility clinics.
Market Segmentation by Type
- Insemination
- Intracytoplasmic Sperm Injection
- Intrauterine
- IVF Using Donor Eggs
- Others
Rising Incidence of Women Seeking IVF for Pregnancy to Develop Market
Infertility is one of the most serious health issues that people around the world face. According to the WHO, 8%-10% of couples worldwide suffer from infertility, totaling approximately 80 million couples. Also, male infertility accounts for 30% of infertility cases and contributes to roughly one-fifth of infertility cases, according to the American Pregnancy Association.
However, the average age at which women and men marry and have their first child is rising. As a result of this trend, more women are seeking In Vitro Fertilization treatment. Furthermore, to focus on their careers, many women freeze their eggs to have a child later on. This growing reliance on fertility treatments is projected to drive the IVF market growth.
Purchase This Comprehensive Research Report for Valuable Market Insights: https://www.extrapolate.com/complete-checkout-buy/87497
Rising Number of Individuals Suffering from PCOS in North America to Gain Traction
In 2022, the North American market will dominate the in vitro fertilization market. Given the prevalence of co-diseases such as polycystic ovary syndrome (PCOS), and government support for sperm and egg storage, the market is expanding. IVF success rates for women under 35 in the United States increased slightly overall in 2020, with 47.2% of cycles ending in one child, compared to women over 40 who used their eggs and embryos, where 7.2% of cycles resulted in live births.
Market expansion is aided by the presence of established market participants, new products, and increased product knowledge. For example, CCRM Fertility is looking for participants for a new in vitro maturation (IVM) trial in April 2023 to stimulate the ovaries, which is less expensive than IVF and has fewer side effects.
Growing Awareness of IVF Treatments in Asia Pacific to Advance Market Growth
The Asia Pacific region is experiencing the fastest growth in the fertility market, which is being fueled by a variety of factors. Significant growth in medical tourism, increased awareness of IVF treatment availability, expansion of fertility clinics in the area, rising healthcare costs, and increased use of assisted reproductive technology in developing countries.
Furthermore, the prevalence of infertility has increased as a result of lifestyle changes such as an increase in stress and obesity, a decrease in physical activity, poor eating habits, inadequate nutrition, and increased pollution, as well as the prevalence of medical conditions such as diabetes, which drives the in-vitro fertilization market (IVF) market growth.
For more information on the report, visit: https://www.extrapolate.com/healthcare-medical-devices-biotechnology/in-vitro-fertilization-market/87497
Key Points from TOC:
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.3. Market Drivers
3.4. Market Restraints
3.5. Market Opportunities
3.6. Market Challenges
3.7. Porter's Five Forces Analysis
Chapter 4. COVID-19 Impact on the Global In Vitro Fertilization Market
Chapter 5. Global In Vitro Fertilization Market Overview, By Product, 2018 - 2032 (USD Million)
Chapter 6. Global In Vitro Fertilization Market Overview, By Type, 2018 - 2032 (USD Million)
Chapter 7. Global In Vitro Fertilization Market Overview, By Cycle, 2018 - 2032 (USD Million)
Chapter 8. Global In Vitro Fertilization Market Overview, By End User, 2018 - 2032 (USD Million)
Chapter 9. Global In Vitro Fertilization Market Overview, By Geography, 2018 - 2032 (USD Million)
Chapter 10. North America In Vitro Fertilization Market Overview, By Countries, 2018 - 2032 (USD Million)
Chapter 11. Europe In Vitro Fertilization Market Overview, By Countries, 2018 - 2032 (USD Million)
Chapter 12. Asia Pacific In Vitro Fertilization Market Overview, By Countries, 2018 - 2032 (USD Million)
Chapter 13. Middle East & Africa In Vitro Fertilization Market Overview, By Countries, 2018 - 2032 (USD Million)
Chapter 14. South America In Vitro Fertilization Market Overview, By Countries, 2018 - 2032 (USD Million)
Chapter 15. Competitive Landscape
15.1. Competitive environment, 2022
15.2. Strategic Framework
15.2.1. Partnership/agreement
15.2.2. Expansion
15.2.3. Mergers & Acquisitions
15.2.4. Recent development
Chapter 16. Key Vendor Analysis
16.1. Cook Group Incorporated
16.1.1. Company Overview
16.1.2. Financial performance
16.1.3. Product Benchmarking
16.1.4. Recent initiatives
16.2. CooperSurgical, Inc.
16.2.1. Company Overview
16.2.2. Financial performance
16.2.3. Product Benchmarking
16.2.4. Recent initiatives
16.3. Corning Incorporated
16.3.1. Company Overview
16.3.2. Financial performance
16.3.3. Product Benchmarking
16.3.4. Recent initiatives
16.4. Ferring B.V.
16.5. FUJIFILM Corporation
16.6. Koninklijke Philips N.V.
16.7. Merck KGaA
16.8. Thermo Fisher Scientific, Inc.
16.9. VITROLIFE AB
16.10. ZEISS Group
16.11. Others
Chapter 17. Sourcing Strategy and Downstream Buyers
17.1. In Vitro Fertilization Market Industrial Chain Analysis
17.2. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Product Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Product Progress in Related Size
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
...TOC Continued
About Us:
Extrapolate is a Global Market Research, Advisory, and Consulting firm that works closely with Industry experts from various industries to bring the latest and most accurate research reports.
In an era of breakneck change and a low tolerance for missed or misread opportunities, businesses need astute guidance to shape markets - not merely respond to them. Extrapolate helps clients develop market perspectives that drive success.
Contact Us
Extrapolate
Phone: (+1) 888 328 2189
E-mail: talk@extrapolate.com
Website: https://www.extrapolate.com
Blog: https://www.extrapolate.com/blog
Follow Us: LinkedIn | Facebook | Twitter
